Churchill Capital Corp X (CCCX) files with the U.S. Securities and Exchange Commission as a blank check company listed on Nasdaq. This SEC filings page allows investors to review the company’s regulatory documents, which are central to understanding its structure as a special purpose acquisition company and its proposed business combination with ColdQuanta, Inc. (Infleqtion).
Key filings for Churchill Capital Corp X include current reports on Form 8-K, which disclose material events. One such Form 8-K describes the Agreement and Plan of Merger and Reorganization among Churchill Capital Corp X, two merger subsidiaries, and ColdQuanta, Inc., and notes the confidential submission of a draft registration statement on Form S-4. Subsequent communications reference the filing of a joint Form S-4 that includes a preliminary proxy statement/prospectus for Churchill Capital Corp X shareholders.
Through this page, users can access the company’s registration statements, proxy materials related to the proposed transaction, and other Exchange Act reports. These documents outline the terms of the business combination, the securities to be issued, and the risk factors associated with the transaction and the combined company. They also provide details on Churchill Capital Corp X’s units, Class A ordinary shares, and warrants listed on Nasdaq.
Stock Titan enhances these filings with AI-powered summaries that explain complex sections in plain language, helping readers interpret items such as merger terms, forward-looking statements, and risk disclosures. As new filings are made available through EDGAR, they are reflected here so that investors can review the latest information on CCCX, the proposed Infleqtion merger, and any subsequent corporate actions.
Use this page to examine Churchill Capital Corp X’s 8-K reports, registration statements on Form S-4, and related proxy and prospectus materials, and to understand how the company’s SPAC structure and planned business combination are documented in its official SEC submissions.
Churchill Capital Corp X has filed a communication about its proposed business combination with quantum technology company ColdQuanta, Inc. (Infleqtion) and the plan to take Infleqtion public. In a detailed interview, Infleqtion’s CEO describes a platform built on neutral atom quantum technology used for precision clocks, sensors and quantum computers, all operating at room temperature through laser-controlled atomic systems.
The discussion highlights applications in GPS‑independent timing, national security, cryptography, drug discovery, AI acceleration and space-based quantum systems, including work with NASA and U.S. defense customers. Management emphasizes that Infleqtion is already selling quantum sensing products and intends to use new capital from going public to accelerate commercialization and reach logical qubits that can unlock quantum advantage in areas like materials science and advanced computing.
Churchill Capital Corp X filed its quarterly report, highlighting its May IPO of 41.4 million units at $10.00 and a Trust Account balance of $419.6 million at redemption value as of September 30, 2025. The company reported a Q3 net loss of $33.4 million, driven mainly by a non-cash $30.5 million loss from the change in fair value of a subscription agreement liability and $6.0 million of subscription agreement expense, partly offset by $4.4 million of interest income on Trust investments.
Churchill entered a definitive Merger Agreement on September 8, 2025 to combine with ColdQuanta, Inc. and signed PIPE subscription agreements for $126.5 million at $10.00 per share, recorded as a $36.5 million liability at quarter-end. Liquidity at September 30, 2025 included cash of $1.14 million and a working capital deficit of $35.2 million. As of November 12, 2025, shares outstanding were 41,700,000 Class A and 10,350,000 Class B, with 10,350,000 public warrants outstanding.
Churchill Capital Corp X (CCCX) filed a Rule 425 communication featuring Infleqtion’s announcement that Ilan Hart has been appointed chief financial officer, effective October 20, 2025, as the company prepares to go public via a business combination with CCCX.
Infleqtion reports approximately $29 million in trailing twelve‑month revenue as of June 30, 2025, reflecting an ~80% CAGR over two years, and expects about $50 million of booked and awarded business at year‑end 2025, with a potential pipeline exceeding $300 million. The definitive agreement values Infleqtion at a pre‑money equity value of $1.8 billion and is expected to deliver over $540 million in gross transaction proceeds, including over $125 million from a common stock PIPE, assuming no redemptions.
Hart will oversee capital markets strategy, investor relations, and long‑term financial planning as Infleqtion scales its neutral‑atom quantum computing and precision sensing platform.
Churchill Capital Corp X announced the confidential submission of a draft Form S-4 to the SEC on October 29, 2025, advancing its proposed business combination with Infleqtion (also referred to as ColdQuanta, Inc. in prior disclosures). The filing will include proxy materials for Churchill’s shareholder vote and a prospectus for securities to be issued in connection with the transaction.
The accompanying press release states the deal is expected to deliver over $540 million in gross proceeds, assuming no redemptions, including more than $125 million from a common stock PIPE at the transaction valuation. Upon closing, the combined company will operate as “Infleqtion, Inc.” and is expected to list on a leading North American exchange under the ticker “INFQ.” The transaction remains subject to SEC effectiveness of the S-4, Churchill shareholder approval, and other customary closing conditions, and is expected to close in Q1 2026.
Churchill Capital Corp X announced that, together with ColdQuanta, it confidentially submitted a draft registration statement on Form S-4 to the SEC on October 29, 2025, in connection with their previously disclosed merger agreement signed on September 8, 2025.
The proposed transaction will be presented to Churchill shareholders for a vote. After the Form S-4 is filed and declared effective, a definitive proxy statement/prospectus and related materials will be mailed to shareholders of both companies as of the record date. A joint press release dated November 4, 2025 was furnished as Exhibit 99.1.
Merus Global Investments, LLC reports beneficial ownership of 1,776,660 Class A ordinary shares of Churchill Capital Corp X, representing 4.3% of the 41,700,000 shares outstanding used for the calculation as of August 13, 2025. The filer indicates sole voting and sole dispositive power over all reported shares and states the holdings are not intended to change or influence control of the issuer. The filing lists the issuer's principal office in Austin, TX and the reporting person's principal office in New York, NY. The statement classifies the position as ownership of 5% or less.